Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 68 (5) , 1538-1550.e2
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Translational Relevance and Recent Advances of Animal Models of Abdominal Aortic AneurysmArteriosclerosis, Thrombosis, and Vascular Biology, 2017
- Silencing of hypoxia inducible factor-1α gene attenuated angiotensin Ⅱ-induced abdominal aortic aneurysm in apolipoprotein E-deficient miceAtherosclerosis, 2016
- Inhibiting the Th17/IL-17A–Related Inflammatory Responses With Digoxin Confers Protection Against Experimental Abdominal Aortic AneurysmArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Experimental Abdominal Aortic Aneurysm Formation Is Mediated by IL-17 and Attenuated by Mesenchymal Stem Cell TreatmentCirculation, 2012
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYCNature Communications, 2012
- Hyperglycemia limits experimental aortic aneurysm progressionJournal of Vascular Surgery, 2010
- 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor-1α and Suppresses Growth of Lesions in a Mouse Model of EndometriosisThe American Journal of Pathology, 2008
- [The expression and significance of hypoxia-inducible factor-1 alpha and related genes in abdominal aorta aneurysm].2004
- 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIFCancer Cell, 2003
- HIF-1α Is Essential for Myeloid Cell-Mediated InflammationCell, 2003